Risk assessment of hepatotoxicity among tuberculosis and human immunodeficiency virus/AIDS-coinfected patients under tuberculosis treatment

Article English OPEN
Williams Ngouleun; Prosper Cabral Biapa Nya; Anatole Constant Pieme; Phelix Bruno Telefo;
  • Publisher: Wolters Kluwer Medknow Publications
  • Journal: International Journal of Mycobacteriology,volume 5,issue 4,pages482-488 (issn: 2212-5531, eissn: 2212-554X)
  • Related identifiers: doi: 10.1016/j.ijmyco.2016.05.003
  • Subject: AST | Hepatotoxicity | Tuberculosis | ALT | Microbiology | AIDS | QR1-502 | Coinfection

Objective/background: Tuberculosis (TB) is a worldwide public health problem. It is a contagious and grave disease caused by Mycobacterium tuberculosis. Current drugs such as isoniazid, pyrazinamide, and rifampicin used for the treatment of tuberculosis are potentially ... View more
Share - Bookmark